Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • SAVIENT PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 78.60 M 142.42 M 179.40 M 75.37 M 25.28 M
    Net Receivables 6.35 M 10.77 M 4.16 M 18.35 M 15.54 M
    Total Inventories 1.89 M 2.64 M 4.20 M 9.42 M 11.45 M
    Progress Payments & Others -6.32 M -7.92 M -8.30 M -7.74 M -6.06 M
    Prepaid Expenses 2.72 M — — — —
    Other Current Assets 2.78 M 3.10 M 7.10 M 0.00 83.23 M
    Current Assets Total 89.62 M 158.93 M 194.86 M 105.86 M 135.50 M
    Long Term Receivables 1.71 M 1.78 M 616,000.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 1.30 M 1.30 M 1.28 M 1.28 M 0.00
    Property, Plant & Equipment Net 1.39 M 1.60 M 1.14 M 6.14 M 6.98 M
    Property, Plant & Equipment Gross 10.04 M 9.77 M 8.95 M 19.91 M 20.41 M
    Accumulated Depreciation 8.65 M 8.17 M 7.81 M 13.77 M 13.43 M
    Other Assets 0.00 0.00 0.00 109.40 M 114.72 M
    Deferred Charges 0.00 0.00 — — —
    Tangible Other Assets 0.00 0.00 0.00 1.64 M 2.91 M
    Intangible Other Assets 0.00 0.00 0.00 107.76 M 111.81 M
    Total Assets 94.02 M 163.62 M 197.89 M 222.69 M 257.20 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 0.00 5.90 M
    Accrued Payroll 2.32 M 3.42 M 2.54 M 0.00 0.00
    Income Taxes Payable 760,000.00 1.69 M 1.31 M 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 16.02 M 10.32 M 11.76 M 15.12 M 36.60 M
    Current Liabilities Total 24.99 M 19.18 M 20.16 M 20.87 M 50.99 M
    Long Term Debt 164,000.00 223,000.00 0.00 0.00 0.00
    Provision for Risks & Charges 0.00 0.00 5.85 M — —
    Deferred Taxes -4.20 M -3.56 M 20.43 M 21.65 M 9.20 M
    Deferred Income 0.00 10.18 M 7.84 M — —
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 9.64 M 8.70 M 43,000.00 0.00 0.00
    Total Liabilities 30.60 M 24.55 M 20.21 M 41.30 M 82.82 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 63.42 M 139.06 M 177.69 M 181.39 M 174.38 M
    Common Stock 547,000.00 537,000.00 523,000.00 615,000.00 606,000.00
    Capital Surplus 214.47 M 204.66 M 189.50 M 221.62 M 218.70 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 24,000.00 1.31 M 1.98 M 676,000.00 2.57 M
    Unappropriated (Free) Reserves 0.00 — — — —
    Retained Earnings -151.61 M -67.44 M -14.32 M -41.52 M -47.49 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 — —
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 0.00 — —
    Treasury Stock 0.00 0.00 0.00 — —
    Total Liabilities & Shareholders Equity 94.02 M 163.62 M 197.89 M 222.69 M 257.20 M
    Common Shares Outstanding 54.65 M 53.71 M 52.31 M 61.52 M 60.46 M